Kumawat Devesh, Ahmed Nishat H, Venkatesh Pradeep
Dr. Rajendra Prasad Centre for Ophthalmic Sciences, New Delhi, India.
Ocular Microbiology, All India Institute of Medical Sciences, New Delhi, India.
Indian J Ophthalmol. 2025 Jun 1;73(6):822-825. doi: 10.4103/IJO.IJO_3071_24. Epub 2025 May 28.
Millipore filters are routinely used in vitreous surgeries for loading intraocular gas. This study purports to establish feasibility of in-line Millipore filter as a filtration barrier and rationalize their use during intravitreal antivascular endothelial growth factor (antiVEGF) injection to reduce the risk of endophthalmitis.
Proof-of-concept in-vitro study.
At the Ocular Microbiology section of a tertiary care eye center in North India, bacterial broths of various microorganisms (Staphylococcus aureus, Staphylococcus epidermidis, Pseudomonas aeruginosa, Escherichia coli, Corynebacterium species, Streptococcus species, and a mixture of Staphylococcus aureus and Pseudomonas aeruginosa) of different concentrations (McFarland 0.5 and McFarland 1) were inoculated onto blood, chocolate, and/or MacConkey agar with (Group 1) or without (Group 2) in-line sterile Millipore filter of 0.22-micron pore size (Set GS Mini filter, ARCEOLE, France). The filter was attached to a one-ml syringe with bacterial broth solution at one end and a 30-gauge needle at the other. Culture plates were incubated and observed daily for colony formation with photographic documentation for up to 5 days.
Bacterial broths could be injected across the filter with little resistance. None of the culture media showed growth when filters were used, compared with growth in all culture plates when inoculation of broth was done without the filter. The fluid loss in the filter (dead space volume) ranged from 0.12 to 0.17 ml.
Millipore filter act as an effective filtration barrier and could enhance the safety of intravitreal antiVEGF injection by reducing the risk of endophthalmitis. Further microbiological and toxicology studies are essential before their integration into clinical practice.
密理博滤器常用于玻璃体手术中填充眼内气体。本研究旨在确定在线密理博滤器作为过滤屏障的可行性,并使其在玻璃体内注射抗血管内皮生长因子(抗VEGF)期间的使用合理化,以降低眼内炎的风险。
概念验证体外研究。
在印度北部一家三级眼科护理中心的眼微生物学部门,将不同浓度(麦氏浊度0.5和麦氏浊度1)的各种微生物(金黄色葡萄球菌、表皮葡萄球菌、铜绿假单胞菌、大肠杆菌、棒状杆菌属、链球菌属以及金黄色葡萄球菌和铜绿假单胞菌的混合物)的细菌肉汤接种到有(第1组)或无(第2组)0.22微米孔径的在线无菌密理博滤器(Set GS Mini滤器,ARCEOLE,法国)的血琼脂、巧克力琼脂和/或麦康凯琼脂上。滤器一端连接装有细菌肉汤溶液的1毫升注射器,另一端连接30号针头。培养板进行培养,每天观察菌落形成情况,并拍照记录,持续5天。
细菌肉汤可轻松通过滤器注射。使用滤器时,所有培养基均未显示生长,而不使用滤器接种肉汤时,所有培养板均有生长。滤器中的液体损失(死腔体积)为0.12至0.17毫升。
密理博滤器可作为有效的过滤屏障,通过降低眼内炎风险提高玻璃体内抗VEGF注射的安全性。在将其纳入临床实践之前,进一步的微生物学和毒理学研究至关重要。